Screener
Rhythm Pharmaceuticals, Inc. RYTM Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Cash and cash equivalents | $62,137 | $54,301 |
| Short-term investments | 278,488 | 334,648 |
| Accounts receivable, net | 34,192 | 26,081 |
| Inventory | 28,651 | 25,753 |
| Prepaid expenses and other current assets | 26,622 | 26,133 |
| Total current assets | 430,090 | 466,916 |
| Property and equipment, net | 1,065 | 1,104 |
| Right-of-use asset | 2,936 | 3,049 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s inventories?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported inventories of $28.65M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s inventories changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s inventories increased by 48.3% year-over-year, from $19.32M to $28.65M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s inventories?
- Over 3 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s inventories has grown at a 796.9% compound annual growth rate (CAGR), from $119.25K to $86.05M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude